IFP Advisors
RCKT icon

IFP Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

IFP Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.95K Sell
740
-1,078
-59% -$3.74K ﹤0.01% 4239
2026
Q2 		$6.22K Buy
1,818
+274
+18% +$911 ﹤0.01% 3652
2026
Q1 		$5.53K Buy
1,544
+1,218
+374% +$4.84K ﹤0.01% 3458
2025
Q4 		$1.14K Sell
326
-317
-49% -$1.08K ﹤0.01% 4029
2025
Q3 		$2.1K Sell
643
-39
-6% -$123 ﹤0.01% 3676
2025
Q2 		$1.67K Buy
682
+498
+271% +$2.52K ﹤0.01% 3979
2025
Q1 		$1.23K Buy
184
+170
+1,214% +$1.68K ﹤0.01% 3291
2024
Q4 		$176 Buy
+14
New +$211 ﹤0.01% 3805
2023
Q4 		– Sell
-25
Closed -$512 – 3279
2023
Q3 		$512 Hold
25
– – ﹤0.01% 3105
2023
Q2 		$497 Hold
25
– – ﹤0.01% 3196
2023
Q1 		$496 Hold
25
– – ﹤0.01% 3184
2022
Q4 		$1K Buy
25
+5
+25% +$92 ﹤0.01% 4454
2022
Q3 		$1K Buy
+20
New +$312 ﹤0.01% 4656
2021
Q2 		– Sell
-15
Closed -$651 – 3200
2021
Q1 		$0 Sell
15
-1
-6% -$55 ﹤0.01% 3187
2020
Q4 		$0 Buy
+16
New +$583 ﹤0.01% 3068

Other funds holding RCKT

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

IFP Advisors's RCKT Position: Q3 2026 in Review

IFP Advisors reduced its Rocket Pharmaceuticals (RCKT) stake by 59% in Q3 2026, selling an estimated $3.74K and leaving 740 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4239.

IFP Advisors first reported a position in RCKT in Q4 2020 and has held it in 15 quarters since. The position peaked at $6.22K in Q2 2026. 10 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • IFP Advisors held 740 shares of Rocket Pharmaceuticals worth $1.95K as of Q3 2026.
  • IFP Advisors sold 1,078 Rocket Pharmaceuticals shares in Q3 2026, an estimated $3.74K.
  • Rocket Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4239 holding.
  • IFP Advisors first reported a position in Rocket Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
  • IFP Advisors's Rocket Pharmaceuticals position peaked at $6.22K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.